Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.

New boron-containing chlorin derivatives 9 and 13 as agents for both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT) of cancer were synthesized from photoprotoporphyrin IX dimethyl ester (2) and L-4-boronophenylalanine-related compounds. The in vivo biodistribution and clearance of 9 and 13 were investigated in tumor-bearing mice. The time to maximum accumulation of compound 13 in tumor tissue was one-fourth of that of compound 9, and compound 13 showed rapid clearance from normal tissues within 24h after injection. The in vivo therapeutic efficacy of PDT using 13 was evaluated by measuring tumor growth rates in tumor-bearing mice with 660 nm light-emitting diode irradiation at 3h after injection of 13. Tumor growth was significantly inhibited by PDT using 13. These results suggested that 13 might be a good candidate for both PDT and BNCT of cancer.

[1]  J. Valliant,et al.  The medicinal chemistry of carboranes , 2002 .

[2]  K. Mani,et al.  Xylose as a carrier for boron containing compounds. , 2008, Bioorganic & Medicinal Chemistry Letters.

[3]  I. Hall,et al.  From boron analogues of amino acids to boronated DNA: potential new pharmaceuticals and neutron capture agents , 1991 .

[4]  Hiroyuki Nakamura,et al.  Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. , 2007, Organic letters.

[5]  J. V. van Lier,et al.  Metal complexes as photo- and radiosensitizers. , 1999, Chemical reviews.

[6]  M. Vicente,et al.  Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects , 2005, Clinical Cancer Research.

[7]  H. Hojo,et al.  Synthesis of carboranes containing nucleoside bases. Unexpectedly high cytostatic and cytocidal toxicity towards cancer cells , 1992 .

[8]  H. Fankhauser,et al.  Pharmacokinetics of Na2B12H11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical trial of boron neutron capture , 2005, Acta Neurochirurgica.

[9]  D. Slatkin,et al.  Boron neutron capture therapy for glioblastoma multiforme: interim results from the phase I/II dose-escalation studies , 1999, Neurosurgery.

[10]  E. Fukusaki,et al.  Syntheses and screening tests of new chlorin derivatives as photosensitizer , 2005 .

[11]  Stephen B. Kahl,et al.  Synthesis of tetrakis-carborane-carboxylate esters of 2,4-bis-(α,β-dihydroxyethyl)-deuteroporphyrin IX , 1990 .

[12]  T J Dougherty,et al.  PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.

[13]  D. Dolphin,et al.  The preparation of porphyrin S-411 (dehydrocoproporphyrin) and harderoporphyrin from protoporphyrin IX , 1981 .

[14]  P. Hynninen,et al.  Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. , 2004, Journal of photochemistry and photobiology. B, Biology.

[15]  S. Iwamoto,et al.  Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake. , 1995, Journal of medicinal chemistry.

[16]  H. Ban,et al.  Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation. , 2010, Chemistry.

[17]  L. Moroder,et al.  Enantioselective synthesis of S-o-carboranylalanine via methylated bislactim ethers of 2,5-diketopiperazines , 1995 .

[18]  D. Gabel,et al.  Synthesis of a (B12H11S)2− containing glucuronoside as potential prodrug for BNCT , 2005 .

[19]  M. Vicente,et al.  Synthesis of novel carboranylchlorins with dual application in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT). , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[20]  Hideyuki Ito,et al.  Synthesis and biological evaluation of new chlorin derivatives as potential photosensitizers for photodynamic therapy. , 2013, Bioorganic & medicinal chemistry.

[21]  T J Dougherty,et al.  Photoradiation in the treatment of recurrent breast carcinoma. , 1979, Journal of the National Cancer Institute.

[22]  J. Moan.  PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY , 1986, Photochemistry and photobiology.

[23]  P. Chauvel,et al.  Selective delivery of 10B to soft tissue sarcoma using 10B-L-borophenylalanine for boron neutron capture therapy. , 1998, The British journal of radiology.

[24]  T. Wieman,et al.  Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  M. Hawthorne.  The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer , 1993 .

[26]  J. Zee,et al.  Heating the patient: a promising approach? , 2002 .

[27]  T. Kageji,et al.  Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors , 1997, Journal of Neuro-Oncology.

[28]  Masaaki Kawahara,et al.  Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. , 2003, Lung cancer.

[29]  R. Barth,et al.  The Chemistry of Neutron Capture Therapy. , 1998, Chemical reviews.

[30]  K. Lamborn,et al.  Synthesis and comparative toxicology of a series of polyhedral borane anion-substituted tetraphenyl porphyrins. , 2007, Journal of medicinal chemistry.

[31]  T. Liao,et al.  Boron-Substituted Pyrimidines , 1964 .

[32]  P. Micca,et al.  Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice. , 2006, Bioorganic & medicinal chemistry.